Krishna Institute of Medical Sciences Limited has informed the Exchange about Action(s) initiated or orders passed
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Smallcap 250 and 1.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krishna Institute of Medical Sciences Limited (KIMS) informed exchanges that its subsidiary, Spanv Medisearch Lifesciences Private Limited, received a GST demand order of Rs. 12.42 crores (including interest and penalty) from the Office of the Deputy Commissioner of State Tax (GST), Nagpur, dated 31st December 2025. The order, passed under Section 73 of GST law for FY 2021-22, pertains to alleged non-payment of GST on medicines consumed by inpatients. The subsidiary has been directed to settle the dues by 30th March 2026. The company is currently examining the matter with its legal and tax advisors and is exploring options including filing an appeal before the relevant appellate authority.
The Rs. 12.42 crore demand is a material tax liability for the subsidiary and could impact consolidated financials if upheld. However, since the company intends to appeal, the final outcome remains uncertain. Near-term sentiment may see mild pressure on the stock, though the amount is relatively small compared to KIMS's overall scale.